Skip to main content

Table 2 Details of pneumothorax events during pazopanib treatment

From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

Patient characteristics Clinical status at the occurrence of pneumothorax
No. Age Pathological diagnosis Treatment day Grade Bilateral Chest drainage
1 60’s Undifferentiated sarcoma, NOS 115 1 No No
2 40’s Carcinosarcoma 12 3 No Yes
3 20’s Undifferentiated sarcoma, NOS 6 3 No Yes
25 3 No Yes
61 3 Yes Yes
129 2 No Yes
144 3 No Yes
4 20’s Synovial sarcoma 55 3 No Yes
95 3 Yes Yes
5 50’s Synovial sarcoma 145 1 No No
174 2 No No
282 1 No No
6 30’s Synovial sarcoma 311 2 No No